ESCO2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Comparison | Statistical significance |
Normal-vs-Primary | 1.66577862614758E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.71221999999416E-05 |
Normal-vs-Stage2 |
3.100400E-02 |
Normal-vs-Stage3 |
1.774590E-04 |
Normal-vs-Stage4 |
5.601200E-03 |
Stage1-vs-Stage2 |
4.235000E-01 |
Stage1-vs-Stage3 |
5.118000E-03 |
Stage1-vs-Stage4 |
1.375600E-02 |
Stage2-vs-Stage3 |
6.970000E-02 |
Stage2-vs-Stage4 |
1.687200E-01 |
Stage3-vs-Stage4 |
7.153200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.39069994303998E-10 |
Normal-vs-AfricanAmerican |
1.809430E-04 |
Normal-vs-Asian |
5.470400E-02 |
Caucasian-vs-AfricanAmerican |
8.027800E-01 |
Caucasian-vs-Asian |
9.959400E-01 |
AfricanAmerican-vs-Asian |
9.238800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
9.86666304214623E-12 |
Normal-vs-Female |
4.9052999999688E-06 |
Male-vs-Female |
8.681600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
3.379400E-04 |
Normal-vs-Extreme_Weight |
2.06039999999241E-05 |
Normal-vs-Obese |
2.391300E-04 |
Normal-vs-Extreme_Obese |
3.323500E-02 |
Normal_Weight-vs-Extreme_Weight |
1.099160E-01 |
Normal_Weight-vs-Obese |
4.041400E-01 |
Normal_Weight-vs-Extreme_Obese |
1.258480E-02 |
Extreme_Weight-vs-Obese |
2.894500E-02 |
Extreme_Weight-vs-Extreme_Obese |
1.096380E-01 |
Obese-vs-Extreme_Obese |
4.183800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.571540E-02 |
Normal-vs-Age(41-60Yrs) |
1.44500000853753E-09 |
Normal-vs-Age(61-80Yrs) |
4.73069999995523E-06 |
Normal-vs-Age(81-100Yrs) |
5.082200E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.883900E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.859700E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.752000E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.541220E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.104000E-03 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.178800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.93890004052122E-09 |
Normal-VS-Type2 PRCC |
1.37389999999016E-06 |
Normal-VS-KIRP CIMP |
4.996900E-03 |
Normal-VS-Unclassified PRCC |
1.575400E-04 |
Type1 PRCC-VS-Type2 PRCC |
1.520180E-02 |
Type1 PRCC-VS-KIRP CIMP |
8.361100E-03 |
Type1 PRCC-VS-Unclassified PRCC |
7.675800E-02 |
Type2 PRCC-VS-KIRP CIMP |
1.494270E-02 |
Type2 PRCC-VS-Unclassified PRCC |
7.081600E-01 |
KIRP CIMP-VS-Unclassified PRCC |
1.325800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.356900E-04 |
Normal-vs-N1 |
1.828180E-04 |
Normal-vs-N2 |
1.502570E-01 |
N0-vs-N1 |
3.278900E-03 |
N0-vs-N2 |
2.628800E-01 |
N1-vs-N2 |
8.360400E-01 |
|
|